Avicanna

About:

Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.

Website: http://avicanna.com

Twitter/X: AvicannaInc

Top Investors: Canaccord Genuity Group, Paradigm Capital, Sprott Inc., Beacon Securities, Natural Sciences and Engineering Research Council of Canada (NSERC)

Description:

Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space. It provides the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms, including API, medical, pharmaceutical, and derma cosmetics. As a multinational organization with vertical integration, Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions. Avicanna was founded in 2016 and is headquartered in Toronto, Ontario, Canada.

Total Funding Amount:

$41.2M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2016-01-01

Contact Email:

info(AT)avicanna.com

Founders:

Aras Azadian, Setu Purohit

Number of Employees:

51-100

Last Funding Date:

2024-04-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai